1: Xiao X, Wang P, Zhang W, Wang J, Cai M, Jiang H, Wu Y, Shan H. GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia. Cancer Cell Int. 2023 Nov 30;23(1):302. doi: 10.1186/s12935-023-03142-y. PMID: 38037057; PMCID: PMC10691066.
2: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. Quizartinib. 2023 Nov 15. PMID: 38051808.
3: Alshamleh I, Kurrle N, Makowka P, Bhayadia R, Kumar R, Süsser S, Seibert M, Ludig D, Wolf S, Koschade SE, Stoschek K, Kreitz J, Fuhrmann DC, Toenges R, Notaro M, Comoglio F, Schuringa JJ, Berg T, Brüne B, Krause DS, Klusmann JH, Oellerich T, Schnütgen F, Schwalbe H, Serve H. PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia. Leukemia. 2023 Dec;37(12):2367-2382. doi: 10.1038/s41375-023-02041-5. Epub 2023 Nov 7. PMID: 37935978; PMCID: PMC10681906.
4: Zheng C, Guo H, Mo Y, Liu G. Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance. Recent Pat Anticancer Drug Discov. 2023 Aug 31. doi: 10.2174/1574892819666230831112815. Epub ahead of print. PMID: 37653627.
5: Ge SS, Qiu QC, Dai HP, Shen XD, Wu TM, Du JH, Wan CL, Shen HJ, Wu DP, Xue SL, Liu SB. Mutation spectrum of FLT3 and significance of non-canonical FLT3 mutations in haematological malignancy. Br J Haematol. 2023 Aug;202(3):539-549. doi: 10.1111/bjh.18877. Epub 2023 May 28. PMID: 37246158.
6: Wang L, Jiang P, Li J, Huang Y, Wen J, Wu Z, Chen Y, Hu J. Loss of MiR-155 Sensitizes FLT3-ITD+AML to Chemotherapy and FLT3 Inhibitors via Glycolysis Blocking by Targeting PIK3R1. J Cancer. 2023 Jan 1;14(1):99-113. doi: 10.7150/jca.54775. PMID: 36605494; PMCID: PMC9809327.
7: Jiang X, Zhang K, Gao C, Ma W, Liu M, Guo X, Bao G, Han B, Hu H, Zhao Z. Activation of FMS-like tyrosine kinase 3 protects against isoprenaline-induced cardiac hypertrophy by improving autophagy and mitochondrial dynamics. FASEB J. 2022 Dec;36(12):e22672. doi: 10.1096/fj.202200419RR. PMID: 36440960.
8: Chen R, Wu W, Chen SY, Liu ZZ, Wen ZP, Yu J, Zhang LB, Liu Z, Zhang J, Luo P, Zeng WJ, Cheng Q. A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis. Front Immunol. 2022 Aug 1;13:831542. doi: 10.3389/fimmu.2022.831542. PMID: 35979347; PMCID: PMC9376251.
9: Cai B, Liu Y, Chong Y, Mori SF, Matsunaga A, Zhang H, Fang X, Chang CS, Cowell JK, Hu T. A truncated derivative of FGFR1 kinase cooperates with FLT3 and KIT to transform hematopoietic stem cells in syndromic and de novo AML. Mol Cancer. 2022 Jul 29;21(1):156. doi: 10.1186/s12943-022-01628-3. PMID: 35906694; PMCID: PMC9336057.
10: Powell RM, Peeters MJW, Rahbech A, Aehnlich P, Seremet T, Thor Straten P. Small Molecule Inhibitors of MERTK and FLT3 Induce Cell Cycle Arrest in Human CD8+ T Cells. Vaccines (Basel). 2021 Nov 8;9(11):1294. doi: 10.3390/vaccines9111294. PMID: 34835225; PMCID: PMC8617686.
11: Yamawaki K, Shiina I, Murata T, Tateyama S, Maekawa Y, Niwa M, Shimonaka M, Okamoto K, Suzuki T, Nishida T, Abe R, Obata Y. FLT3-ITD transduces autonomous growth signals during its biosynthetic trafficking in acute myelogenous leukemia cells. Sci Rep. 2021 Nov 22;11(1):22678. doi: 10.1038/s41598-021-02221-2. PMID: 34811450; PMCID: PMC8608843.
12: Wachholz V, Mustafa AM, Zeyn Y, Henninger SJ, Beyer M, Dzulko M, Piée-Staffa A, Brachetti C, Haehnel PS, Sellmer A, Mahboobi S, Kindler T, Brenner W, Nikolova T, Krämer OH. Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3. Arch Toxicol. 2022 Jan;96(1):177-193. doi: 10.1007/s00204-021-03174-1. Epub 2021 Oct 19. PMID: 34665271; PMCID: PMC8748367.
13: Yang X, Wan M, Yu F, Wu X. Histone methyltransferase EZH2 epigenetically affects CCNA1 expression in acute myeloid leukemia. Cell Signal. 2021 Nov;87:110144. doi: 10.1016/j.cellsig.2021.110144. Epub 2021 Sep 9. PMID: 34509612.
14: Lu X, Han L, Busquets J, Collins M, Lodi A, Marszalek JR, Konopleva M, Tiziani S. The Combined Treatment With the FLT3-Inhibitor AC220 and the Complex I Inhibitor IACS-010759 Synergistically Depletes Wt- and FLT3-Mutated Acute Myeloid Leukemia Cells. Front Oncol. 2021 Aug 20;11:686765. doi: 10.3389/fonc.2021.686765. PMID: 34490088; PMCID: PMC8417744.
15: Liu SB, Dong HJ, Wang J, Qiu QC, Xue SL, Li L. [Effect of FLT3-ITD Length on 32D Cell Proliferation, Apoptosis and Sensitivity to FLT3 Inhibitor]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Aug;29(4):1034-1038. Chinese. doi: 10.19746/j.cnki.issn.1009-2137.2021.04.004. PMID: 34362479.
16: Wang P, Xiao X, Zhang Y, Zhang B, Li D, Liu M, Xie X, Liu C, Liu P, Ren R. A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia. J Hematol Oncol. 2021 Jul 3;14(1):105. doi: 10.1186/s13045-021-01098-y. PMID: 34217323; PMCID: PMC8255005.
17: Guo D, Zhao Y, Wang N, You N, Zhu W, Zhang P, Ren Q, Yin J, Cheng T, Ma X. GADD45g acts as a novel tumor suppressor, and its activation suggests new combination regimens for the treatment of AML. Blood. 2021 Aug 12;138(6):464-479. doi: 10.1182/blood.2020008229. PMID: 33945602.
18: Liu Y, Wei J, Liu J, Ma W, Duan Y, Liu D. Novel AXL-targeted agents overcome FLT3 inhibitor resistance in FLT3-ITD+ acute myeloid leukemia cells. Oncol Lett. 2021 May;21(5):397. doi: 10.3892/ol.2021.12658. Epub 2021 Mar 18. PMID: 33777220; PMCID: PMC7988696.
19: An X, Liu J, Wang N, Wang D, Huang L, Zhang L, Cai J, Wery JP, Zhou D, Zhou J, Li QX. Corrigendum to "AC220 and AraC cause differential inhibitory dynamics in patient-derived M5-AML with FLT3-ITD and, thus, ultimately distinct therapeutic outcomes" [Experimental Hematology 2017;45:36-44]. Exp Hematol. 2021 Jan;93:85. doi: 10.1016/j.exphem.2020.10.004. Epub 2020 Nov 12. Erratum for: Exp Hematol. 2017 Jan;45:36-44.e2. doi: 10.1016/j.exphem.2016.09.004. PMID: 33189657.
20: Garcia-Horton A, Yee KW. Quizartinib for the treatment of acute myeloid leukemia. Expert Opin Pharmacother. 2020 Dec;21(17):2077-2090. doi: 10.1080/14656566.2020.1801637. Epub 2020 Aug 9. PMID: 32772726.